↓ Skip to main content

Myeloid cell reprogramming alleviates immunosuppression and promotes clearance of metastatic lesions

Overview of attention for article published in Frontiers in oncology, November 2022
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (68th percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

twitter
6 X users

Readers on

mendeley
10 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Myeloid cell reprogramming alleviates immunosuppression and promotes clearance of metastatic lesions
Published in
Frontiers in oncology, November 2022
DOI 10.3389/fonc.2022.1039993
Pubmed ID
Authors

Ravi M. Raghani, Jeffrey A., Yining Zhang, Sophia M. Orbach, Jing Wang, Mina Zeinali, Sunitha Nagrath, Sandeep Kakade, Qichen Xu, Joseph R. Podojil, Tushar Murthy, Adam Elhofy, Jacqueline S. Jeruss, Lonnie D. Shea

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 10 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 10 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 3 30%
Researcher 2 20%
Student > Bachelor 1 10%
Unknown 4 40%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 2 20%
Medicine and Dentistry 2 20%
Neuroscience 1 10%
Immunology and Microbiology 1 10%
Unknown 4 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 December 2022.
All research outputs
#8,126,547
of 25,801,916 outputs
Outputs from Frontiers in oncology
#2,977
of 22,805 outputs
Outputs of similar age
#155,354
of 493,209 outputs
Outputs of similar age from Frontiers in oncology
#170
of 1,500 outputs
Altmetric has tracked 25,801,916 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 22,805 research outputs from this source. They receive a mean Attention Score of 3.1. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 493,209 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.
We're also able to compare this research output to 1,500 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.